文献速递临床试验与 GCP流行病学与生物统计

减少即食治疗食品剂量在社区管理重度急性营养不良中的有效性:刚果民主共和国一项非劣效性随机对照试验

Effectiveness of a reduced dose of ready-to-use therapeutic food in community-based management of severe acute malnutrition: A non-inferiority randomized controlled trial in the Democratic Republic of Congo.
PubMed 文献 · PLoS Med · 2025-05-16

在刚果民主共和国高粮食不安全地区14个卫生中心纳入968名6-59月龄无并发症重度急性营养不良儿童,随机分为标准WHO即食治疗食品剂量组与从治疗第三周起减量组。减量组与标准组体重增长速度无差异,项目结局相似,但减量组上臂围增长速度较低。

要点

  • 减量组与标准组体重增长速度无差异:4.88±2.36 vs 5.09±2.28 g/kg/d,差值-0.09 g/kg/d(95%CI -0.33至0.15;p=0.46)。
  • 恢复率、失访率、违约率、3个月复发率及平均住院时长两组相似。
  • 减量组上臂围增长速度较低:平均差值-0.13 mm/周(95%CI -0.25至-0.01;p=0.04)。

核心结论

  • 从治疗第三周起减少即食治疗食品剂量的策略,在严重粮食不安全背景下,对体重增长速度和项目结局与标准剂量策略同样有效。
  • 减量组上臂围增长速度较低。
  • 未来研究应探讨减量策略在高风险因素亚组儿童中的有效性。

研究设计与样本

  • 个体随机非劣效性试验,在刚果民主共和国东开赛省Bonzola和Nzaba卫生区14个卫生中心开展。
  • 纳入968名6-59月龄无医疗并发症的重度急性营养不良儿童。
  • 儿童随机分配至标准WHO即食治疗食品剂量组或从治疗第三周起减量即食治疗食品剂量组。
  • 主要结局为从入组至出院时体重增长速度;次要结局包括人体测量、项目结局和复发。
  • 采用以卫生中心为随机截距的混合效应线性与逻辑回归模型比较两组差异。

主要发现

  • 近94%的儿童来自严重粮食不安全家庭。
  • 体重增长速度:减量组4.88±2.36 g/kg/d vs 标准组5.09±2.28 g/kg/d,差值-0.09 g/kg/d(95%CI [-0.33, 0.15];p=0.46)。
  • 恢复率:减量组64.3% vs 标准组67.0%;失访率:减量组4.69% vs 标准组5.23%;违约率:减量组2.65% vs 标准组1.88%。
  • 3个月复发率:减量组2.86% vs 标准组2.40%;平均住院时长:减量组42天 vs 标准组43天。
  • 上臂围增长速度从第三周起减量组低于标准组,平均差值-0.13 mm/周(95%CI [-0.25, -0.01];p=0.04)。

临床怎么用

  • 作者认为,在严重粮食不安全背景下,从治疗第三周起减少即食治疗食品剂量的策略对体重增长速度和项目结局与标准剂量策略同样有效。
  • 作者指出减量组上臂围增长速度较低。
  • 作者建议未来研究应探讨减量策略在高风险因素亚组儿童中的有效性。

局限性

  • 未来研究应探讨减量策略在高风险因素亚组儿童中的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The reduced Ready-to-use Therapeutic Food (RUTF) dose strategy was demonstrated effective in recovering children with Severe Acute Malnutrition (SAM) in ideal conditions and in a context of food security. The present study was conducted to provide further evidence on the effectiveness of reduced RUTF dose in a context of high food insecurity and post conflict humanitarian crisis, and with routine health staff. METHODS AND FINDINGS: An individually randomized non-inferiority trial was conducted in 968 children aged 6-59 months suffering from SAM without medical complications in 14 health centers in the Bonzola and Nzaba health zones of Kasaï Oriental, Democratic Republic of Congo (DRC). Children were randomly assigned to either a control group receiving the standard WHO (World Health Organization) RUTF dose at the time or an intervention group receiving a reduced RUTF dose starting from the third week of treatment. The primary outcome was weight gain velocity from admission to discharge from treatment, while secondary outcomes included anthropometry measurements, programmatic outcomes and relapse. Mixed effects linear and logistic regression models with the health center as random intercept were used to compare differences between the two study groups. Close to 94% of the children were from severely food insecure households. There was no difference in weight gain velocity between the two groups (4.88 ± 2.36 g/kg/d reduced dose group versus 5.09 ± 2.28 g/kg/d standard dose group; difference -0.09 g/kg/d (95% CI [-0.33, 0.15]; p = 0.46). Programmatic outcomes were also similar between the two groups: recovery rate (64.3% versus 67.0%), loss to follow-up (4.69% versus 5.23%), defaulter rate (2.65% and 1.88%), relapse rate over 3 months (2.86% versus 2.40%) and mean length of stay (42 versus 43 days). Nevertheless, the rate of mid-upper arm circumference (MUAC) gain from the third week onwards was lower in the reduced-dose group than in the standard-dose group, with a mean difference of -0.13 mm/week (95% CI [-0.25, -0.01]; p = 0.04). There was no difference in terms of serious adverse events, in the reduced versus standard dose: weight loss (2.24% versus 1.26%), weight stagnation (14.9% versus 17.0%), and medical complications (4.08% versus 3.77%). Important effect modifiers identified were: child sex, child age, season of admission and missed treatment visits. CONCLUSIONS: The strategy of a reduced RUTF dose starting from the third week of treatment is as effective as the standard dose strategy on weight gain velocity and programmatic outcomes in a context of severe food insecurity. However, MUAC gain velocity was lower in the reduced dose group. Future studies should investigate the effectiveness of a reduced dose strategy among sub group of children with high risk factors. Trial registration: International Standard Randomized Controlled Trial Network (ISRCTN15258669).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Ntaongo Alendi J, Salpeteur C, Botomba S, et al. Effectiveness of a reduced dose of ready-to-use therapeutic food in community-based management of severe acute malnutrition: A non-inferiority randomized controlled trial in the Democratic Republic of Congo. PLoS Med. 2025. PMID: 40378371. doi:10.1371/journal.pmed.1004606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。